Ability Biotherapeutics
PrivateLast Round
Seed
Jun 18, 2024
Total Funding Raised
$30M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ability Biotherapeutics is a biotechnology company that develops logic-gated antibody therapeutics for cancer and autoimmune diseases using its proprietary AI-powered discovery platform, AbiLeap™.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ability Biotherapeutics Comparables
Compare Ability Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthetic Design Lab | 84% | |
| Tentarix Biotherapeutics | 81% | |
| LabGenius Therapeutics | 80% |
Ability Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 18, 2024 | ||||
| Seed | Dec 6, 2023 |
Key People
Founding team and executive leadership
Ability Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Seed |
| Amplitude Ventures | Seed |
| Investissement Québec | Seed |
| Fonds de solidarité FTQ | Seed |
| Alexandria Venture Investments | Seed |
| Seido Capital | Seed |
| Theodorus | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 55% MoM.
- Aug 5, 2026
Grew 24% QoQ, from 25 to 31 employees.
Ability Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ability Biotherapeutics's valuation, stock price, and market status.
Is Ability Biotherapeutics a public or private company?
Ability Biotherapeutics is a private company.
What is the current stock price of Ability Biotherapeutics?
Ability Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Ability Biotherapeutics worth (valuation)?
Valuation information for Ability Biotherapeutics is not publicly available.
Can I buy Ability Biotherapeutics stock?
Ability Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ability Biotherapeutics's last funding round?
Ability Biotherapeutics's most recent funding round was Seed on June 18, 2024.
Who are the main investors in Ability Biotherapeutics?
Key investors in Ability Biotherapeutics include Amplitude Ventures.
Will Ability Biotherapeutics IPO soon?
No public IPO plans have been announced for Ability Biotherapeutics.
How can I track Ability Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ability Biotherapeutics's secondary market activity and sign up for updates.